CClinicalTrials.gg
TerminatedNCT01396304Updated Feb 15, 2013

Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers

A Phase 4 interventional study of Restore Calcium Alginate Dressing and AquaCel Ag Wound Dressing in Venous Ulcer and Infection, sponsored by Hollister Wound Care LLC. Terminated at 5 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-02-15.

Sponsored by Hollister Wound Care LLC · Phase 4, Interventional, and Treatment

Why this study was terminated
slow accrual
Phase
Phase 4
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Calcium alginate dressings with silver have been found to be safe and effective for use for leg ulcers. The primary objective is to compare Restore Calcium Alginate Dressing, Silver to AqualCel Ag Dressing on the following parameters: No further progression toward infection (bioburden), ease of application and removal, and percent progression to closure. The secondary objective is to obtain photographic documentation of the leg ulcers during the course of the study.

02

Conditions studied

  • Venous Ulcer
  • Infection

Keywords

  • leg ulcer
  • infection
  • closure
  • wound dressings
03

In context

Varicose Ulcer

378 studies on the registry are indexed under Varicose Ulcer; 80 are open to participants now.

This study's enrollment of 19 is below the median of 64 across 325 interventional studies indexed under Varicose Ulcer.

Browse Varicose Ulcer studies →

Lead sponsor

This is the only study on the registry with Hollister Wound Care LLC as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Is 18 years or older; male or female.
  2. Previous diagnosis of venous insufficiency proven by a positive venous duplex with reflux.
  3. Has a venous ulcer with a wound area between 5 cm2 - 40 cm2.
  4. Has an ankle brachial index (ABI) >0.8.
  5. Has a venous ulcer with duration less than 24 months.
  6. Has a venous ulcer which is critically colonized (not infected) based on the Lazareth Study Model. Ulcers are considered to be critically colonized if at least three of the five following signs are present:

    Severe spontaneous pain between two dressing changes,Perilesional erythema,Local edema,Malodour,Heavy Exudation

  7. Is currently using Profore as their standard of care.
  8. Has not received antibiotics for 6 weeks prior to enrollment.

Exclusion criteria

Exclusion Criteria

  1. Has an allergy to one of the components of the dressings (calcium alginate, hydrocolloid [carboxymethylceullose], silver).
  2. Is currently on antibiotics.
  3. Has a negative venous duplex.
  4. Is unable to tolerate 4 layer compression.
  5. Is unable to continue contact with the investigator for a period of at least two weeks.
  6. Is unwilling or unable to comply with the study protocol.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • Experimental
    Restore Calcium Alginate Dressing Silver

    Restore Calcium Alginate Dressing Silver under compression wrap

    Device: Restore Calcium Alginate Dressing

  • Active comparator
    Aquacel Ag Wound Dressing

    Aquacel Ag Wound Dressing under compression wrap

    Device: AquaCel Ag Wound Dressing

Interventions

  • DeviceRestore Calcium Alginate Dressing

    Wound dressing appropriate for venous leg ulcers. Dressing to be changed minimally once per week.

  • DeviceAquaCel Ag Wound Dressing

    Wound dressing appropriate for venous leg ulcers. Dressing to be changed minimally once per week.

06

What researchers measure

Primary outcomes

  1. The primary objective is to compare Restore Calcium Alginate Dressing, Silver to AqualCel Ag Dressing on the following parameters: No further progression toward infection (bioburden), ease of application and removal, and percent progression to closure.

    Time frame: Observations will be collected over 6 weeks for a total of 7 visits

Secondary outcomes

  1. The secondary objective is to obtain photographic documentation of the venous leg ulcers during the course of the study.

    Time frame: Observations will be collected over 6 weeks in a total of 7 visits.

07

Study locations

5 sites
  • Palms of Pasadena Hospital
    St. Petersburg, Florida 33707, United States
  • LSU Health Sciences Center
    Shreveport, Louisiana 71103, United States
  • Bayshore Community Hospital
    Holmdel, New Jersey 07733, United States
  • Wound Institute & Research Center
    Dunmore, Pennsylvania 18512, United States
  • Lake Washington Vascular Surgeons
    Bellevue, Washington 98004, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01396304
Lead sponsor
Hollister Wound Care LLC
Responsible party
Sponsor
First posted
Jul 18, 2011
Start date
Oct 2011
Primary completion
Feb 2013
Completion
Feb 2013
Last update
Feb 15, 2013

Study contacts

Rita Kaurs, MSHSA MT NMT
study director · Hollister Incorporated

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion